MPT
Published on 04/30/2026 at 08:29 am EDT
QUARTERLY SUPPLEMENTAL
1Q 2026
COMPANY OVERVIEW
Company Information 3
FINANCIAL INFORMATION
Reconciliation of Funds from Operations 6
Debt Summary 7
Debt Maturities and Debt Metrics 8
PORTFOLIO INFORMATION
Lease and Loan Maturity Schedule 9
Total Assets and Revenues
by Asset Type, Operator, State and Country 10
Rent Coverage 13
Summary of Active Developments
and Capital Addition Projects 15
FINANCIAL STATEMENTS
Consolidated Statements of Income 16 Consolidated Balance Sheets 17 Investments in Unconsolidated Real Estate
Joint Ventures 18
Investments in Unconsolidated Operating Entities 19
Appendix - Non-GAAP Reconciliations 20
FORWARD-LOOKING STATEMENTS
This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements can generally be identified by the use of forward-looking words such as "may", "will", "would", "could", "expect", "intend", "plan", "estimate", "target", "anticipate", "believe", "objectives", "outlook", "guidance" or other similar words, and include statements regarding our strategies, objectives, prospects, industry, asset sales, tenant conditions and anticipated rent. Forward-looking statements involve known and unknown risks and uncertainties that may cause our actual results or future events to differ materially from those expressed in or underlying
such forward-looking statements, including, but not limited to: (i) the risk that projected rents may be lower than anticipated or realized later than expected;
(ii) the risk that the timing, outcome and terms of Prospect's causes of action, that is collateral for DIP and other fundings that remain outstanding, will
not be consistent with those anticipated by the Company; (iii) our success in implementing our business strategy and our ability to identify, underwrite, finance, consummate and integrate acquisitions and investments; (iv) the risk that previously announced or contemplated property sales, loan repayments, and other capital recycling transactions do not occur as anticipated or at all; (v) the risk that MPT is not able to attain its leverage, liquidity and cost of capital objectives within a reasonable time period or at all; (vi) MPT's ability to obtain or modify the terms of debt financing on attractive terms or at all, as a result
of changes in interest rates and other factors, which may adversely impact our ability to pay down, refinance, restructure or extend our indebtedness, including extending our 2026 credit facility, as it becomes due, or pursue acquisition and development opportunities; (vii) the ability of our tenants, operators and borrowers to satisfy their obligations under their respective
contractual arrangements with us; (viii) the ability of our tenants and operators to operate profitably and generate positive cash flow, remain solvent, comply with applicable laws, rules and regulations in the operation of our properties, to deliver high-quality services, to attract and retain qualified personnel and to attract patients; (ix) the risk that we are unable to monetize our investments in certain tenants at full value within a reasonable time period or at all; (x) the risk that the operations of our tenants will be negatively impacted by changes to
Medicaid funding introduced by the OBBBA; and (xi) the risks and uncertainties of litigation or other regulatory proceedings.
The risks described above are not exhaustive and additional factors could adversely affect our business and financial performance, including the risk factors discussed under the section captioned "Risk Factors" in our most recent Annual Report on Form 10-K and our Quarterly Reports on Form 10-Q, and as may be updated in our other filings with the SEC. Forward-looking statements are inherently uncertain and actual performance or outcomes may vary materially from any forward-looking statements and the assumptions on which those statements are based. Readers are cautioned not to place undue reliance on forward-looking statements as predictions of future events. We disclaim any responsibility to update such forward-looking statements, which speak only as of the date on which they were made.
Pictured above: Carrollton Springs - Operated by Lifepoint Behavioral Health - Carrollton Springs, Texas.
On the cover: IMED Alicante - Leased by IMED Hospitales - Alicante, Spain.
COMPANY OVERVIEW
M
edical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003
to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate.
MPT's financing model facilitates acquisitions and recapitalizations and allows operators of hospitals to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.
As of March 31, 2026.
378
properties
~38,000
51
operators
hospital beds
30
U.S. states
9
countries
MPT Officers
Edward K. Aldag, Jr.
R. Steven Hamner
J. Kevin Hanna Rosa H. Williams Larry H. Portal Charles R. Lambert
R. Lucas Savage
Chairman, President and Chief Executive Officer Executive Vice President and Chief Financial Officer
Senior Vice President, Controller and Chief Accounting Officer Senior Vice President of Operations and Secretary
Senior Vice President, Senior Advisor to the CEO Senior Vice President of Finance and Treasurer
Vice President, Head of Global Acquisitions
Board of Directors
Edward K. Aldag, Jr.
G. Steven Dawson
R. Steven Hamner Caterina A. Mozingo Emily W. Murphy Elizabeth N. Pitman
D. Paul Sparks, Jr. Michael G. Stewart
C. Reynolds Thompson, III
Corporate Headquarters
Medical Properties Trust, Inc.
10500 Liberty Parkway
Birmingham, AL 35242
(205) 969-3755 | (205) 969-3756 (fax)
MPT.com
INVESTOR RELATIONS
Contact
Charles Lambert, Senior Vice President of Finance and Treasurer
(205) 397-8897 [email protected]
Transfer
Agent
Equniti Trust Company, LLC 28 Liberty Street, Floor 53 New York, NY 10005
https://equiniti.com/us
Stock Exchange Listing and Trading Symbol
New York Stock Exchange (NYSE): MPT
Pictured above: Hackensack Meridian Mountainside Medical Center - Newark, New Jersey.
FINANCIAL INFORMATION
RECONCILIATION OF NET INCOME (LOSS) TO FUNDS FROM OPERATIONS
(Unaudited)
(Amounts in thousands, except per share data)
March 31, 2026
March 31, 2025
For the Three Months Ended
$ 32,827
(461)
$ (118,275)
(117)
$ 32,366
$ (118,392)
85,882
76,891
2,016
(8,059)
9,037
65,683
$ 129,301
$ 16,123
10,469
13,898
1,632
10,047
(8,462)
9,527
(5,568)
26,609
(45,155)
1,102
-
3,796
$ 82,217
$ 81,102
FFO INFORMATION:
Net income (loss) attributable to MPT common stockholders
Participating securities' share in earnings
Net income (loss), less participating securities' share in earnings
Depreciation and amortization Loss (gain) on sale of real estate Real estate impairment charges Funds from operations
Other impairment charges, net Litigation, bankruptcy and other costs
Share-based compensation (fair value adjustments) (A)
Non-cash fair value adjustments Tax rate changes and other
Debt refinancing and unutilized financing costs
Normalized funds from operations
Certain non-cash and related recovery information:
Share-based compensation (A)
$
9,035
$
8,138
Debt costs amortization
$
7,547
$
6,006
Non-cash rent and interest revenue (B)
$
348
$
-
Cash recoveries of non-cash rent and interest revenue (C)
$
210
$
526
Straight-line rent revenue from operating and finance leases
$
(36,479)
$
(42,619)
$ 0.05
$ (0.20)
0.15
0.13
-
(0.01)
0.02
0.11
$ 0.22
$ 0.03
0.02
0.02
-
0.02
(0.01)
0.02
(0.01)
0.04
(0.08)
-
-
0.01
$ 0.14
$ 0.14
PER DILUTED SHARE DATA:
Net income (loss), less participating securities' share in earnings
Depreciation and amortization Loss (gain) on sale of real estate Real estate impairment charges Funds from operations
Other impairment charges, net Litigation, bankruptcy and other costs
Share-based compensation (fair value adjustments) (A)
Non-cash fair value adjustments Tax rate changes and other
Debt refinancing and unutilized financing costs
Normalized funds from operations
Certain non-cash and related recovery information:
Share-based compensation (A)
$
0.02
$
0.01
Debt costs amortization
$
0.01
$
0.01
Non-cash rent and interest revenue (B)
$
-
$
-
Cash recoveries of non-cash rent and interest revenue (C)
$
-
$
-
Straight-line rent revenue from operating and finance leases
$
(0.06)
$
(0.07)
Notes:
Investors and analysts following the real estate industry utilize funds from operations ("FFO") as a supplemental performance measure. FFO, reflecting the assumption that real estate asset values rise or fall with market conditions, principally adjusts for the effects of GAAP depreciation and amortization of real estate assets, which assumes that the value of real estate diminishes predictably over time. We compute FFO in accordance with the definition provided by the National Association of Real Estate Investment Trusts, or Nareit, which represents net income (loss) (computed in accordance with GAAP), excluding gains (losses) on sales of real estate and impairment charges on real estate assets, plus real estate depreciation and amortization, including amortization related to in-place lease intangibles, and after adjustments for unconsolidated partnerships and joint ventures.
In addition to presenting FFO in accordance with the Nareit definition, we disclose normalized FFO, which adjusts FFO for items that relate to unanticipated or non-core events or activities or accounting changes that, if not noted, would make comparison to prior period results and market expectations less meaningful to investors and analysts. We believe that the use of FFO, combined with the required GAAP presentations, improves the understanding of our operating results among investors and the use of normalized FFO makes comparisons of our operating results with prior periods and other companies more meaningful. While FFO and normalized FFO are relevant and widely used supplemental measures of operating and financial performance of REITs, they should not be viewed as a substitute measure of our operating performance since the measures do not reflect either depreciation and amortization costs or the level of capital expenditures and leasing costs (if any not paid by our tenants) to maintain the operating performance of our properties, which can be significant economic costs that could materially impact our results of operations. FFO and normalized FFO should not be considered an alternative to net income (loss) (computed in accordance with GAAP) as indicators of our results of operations or to cash flow from operating activities (computed in accordance with GAAP) as an indicator of our liquidity.
Certain line items above (such as depreciation and amortization) include our share of such income/expense from unconsolidated joint ventures. These amounts are included with all activity of our equity interests in the "Earnings from equity interests" line on the consolidated statements of income.
Total share-based compensation expense for GAAP purposes is $0.6 million and $17.7 million for the three months ended March 31, 2026 and 2025, respectively (including certain awards that are to be settled in cash). Cash-settled awards are typically recorded in accordance with GAAP at fair value and measured at each balance sheet date until settlement. The resulting fluctuations, which are primarily driven by changes in our stock price rather than operational performance, can introduce significant volatility in our earnings. To enhance comparability and provide a more stable view of performance over time, NFFO reflects an $(8.5) million and $9.5 million adjustment in the three months ended March 31, 2026 and 2025, respectively, to arrive at total share-based compensation expense using grant date fair value for all awards (including cash-settled awards) of $9.0 million and $8.1 million for the three months ended March 31, 2026 and 2025, respectively.
Includes revenue accrued during the period but not received in cash, such as deferred rent, payment-in-kind ("PIK") interest or other accruals.
Includes cash received to satisfy previously accrued non-cash revenue, such as the cash receipt of previously deferred rent or PIK interest.
DEBT SUMMARY
Debt Instrument
Rate Type
Rate
Balance
2026 Secured Credit Facility Revolver(A)(B)
Variable
5.026%
$
665,577
2027 Secured Term Loan
Variable
6.018%
200,000
0.993% Notes Due 2026 (€500M)(B)
Fixed
0.993%
577,650
5.000% Notes Due 2027
Fixed
5.000%
1,400,000
3.692% Notes Due 2028 (£600M)(B)
Fixed
3.692%
793,620
4.625% Notes Due 2029
Fixed
4.625%
900,000
3.375% Notes Due 2030 (£350M)(B)
Fixed
3.375%
462,945
3.500% Notes Due 2031
Fixed
3.500%
1,300,000
7.000% Secured Notes Due 2032 (€1B)(B)
Fixed
7.000%
1,155,300
8.500% Secured Notes Due 2032
Fixed
8.500%
1,500,000
2034 Secured GBP Term Loan (£631M)(B)
Fixed
6.877%
835,126
$
9,790,218
Debt issuance costs and discount
(127,559)
Weighted average rate 5.363%
$
9,662,659
Variable 9%
Fixed
91%
As part of our Credit Facility amendment on February 13, 2025, we provided notice to extend the maturity to June 30, 2027, subject to the satisfaction of certain other conditions. $200 million was repaid on April 1, 2026.
Non-USD denominated debt converted to U.S. dollars at March 31, 2026.
DEBT MATURITIES
Year
Senior Notes
Term Loans/Revolver
Total Debt
% of Total
2026
$ 577,650
$ 665,577
(A)
$ 1,243,227
12.7%
2027
1,400,000
200,000
1,600,000
16.4%
2028
793,620
-
793,620
8.1%
2029
900,000
-
900,000
9.2%
2030
462,945
-
462,945
4.7%
2031
1,300,000
-
1,300,000
13.3%
2032
2,655,300
-
2,655,300
27.1%
2033
-
-
-
-
2034
-
835,126
835,126
8.5%
Totals
$ 8,089,515
$ 1,700,703
$ 9,790,218
100.0%
DEBT BY LOCAL CURRENCY
Senior Notes
Term Loans/Revolver
Total Debt
% of Total
United States dollars
$
5,100,000
$
685,000
$
5,785,000
59.1%
British pound sterling
1,256,565
835,126
2,091,691
21.4%
Euros
1,732,950
115,530
1,848,480
18.9%
Swiss francs
-
65,047
65,047
0.6%
Totals
$ 8,089,515
$ 1,700,703
$ 9,790,218
100.0%
DEBT METRICS (B)
Adjusted Net Debt to Annualized EBITDAre Ratios:
Adjusted Net Debt
Adjusted Annualized EBITDAre
For the Three Months Ended March 31, 2026
$
$
8,693,633
934,688
Adjusted Net Debt to Adjusted Annualized EBITDAre Ratio 9.3x
$
$
8,693,633
932,660
Adjusted Net Debt
Transaction Adjusted Annualized EBITDAre
Unsecured Debt Secured Debt
Total Debt
Total Gross Assets(C)
$ 5,434,215
4,356,003
$ 9,790,218
$ 16,475,959
Financial Leverage
59.4%
Interest Coverage Ratio:
Interest Expense
Capitalized Interest
$ 133,330
2,179
Debt Costs Amortization
(6,983)
Total Interest
Adjusted EBITDAre
$ 128,526
$ 233,672
Adjusted Interest Coverage Ratio
1.8x
Adjusted Net Debt to Transaction Adjusted Annualized EBITDAre Ratio 9.3x Leverage Ratio:
As part of our Credit Facility amendment on February 13, 2025, we provided notice to extend the maturity to June 30, 2027, subject to the satisfaction of certain other conditions.
Not intended to reflect covenants per debt agreements.
Total Gross Assets equals total assets plus real estate accumulated depreciation and amortization. See appendix for reconciliation of Non-GAAP financial measures.
(As of March 31, 2026)
($ amounts in thousands)
Years of Maturities(B)
Total Properties(C)
Base Rent/Interest(D)
Percentage of Total Base Rent/Interest
2026
1
$ 234
0.0%
2027
1
3,782
0.3%
2028
5
7,981
0.7%
2029
4
16,422
1.5%
2030
10
7,301
0.7%
2031
4
4,925
0.4%
2032
21
62,251
5.6%
2033
5
6,201
0.6%
2034
4
21,343
1.9%
2035
7
27,002
2.4%
Thereafter
302
962,740
85.9%
364
$ 1,120,182
100.0%
#
Percentage of total base rent/interest
85.9%
5.6%
0.0%
0.3%
0.7%
1.5%
0.7%
0.4%
0.6%
1.9%
2.4%
100%
90%
80%
70%
60%
50%
40%
30%
20%
10%
0%
(A) Schedule includes leases and mortgage loans and related terms as of March 31, 2026.
(B) Lease/Loan expiration is based on the fixed term of the lease/loan and does not factor in potential renewal or other options provided for in our agreements.
(C) Reflects all properties, including those that are part of joint ventures, except vacant properties (less than 1% of total assets), facilities that are under development, and transitioning properties.
(D) Represents base rent/interest income contractually owed per the lease/loan agreements on an annualized basis as of period end (including foreign currency exchange rates) but does not include tenant recoveries, additional rents and other lease-related adjustments to revenue (i.e., straight-line rents and deferred revenues), or any reserves or write-offs.
(March 31, 2026)
($ amounts in thousands)
Asset Types
Properties
Total Assets(A)
Percentage of Total Assets
Q1 2026
Revenues
Percentage of Q1 2026 Revenues
General Acute Care Hospitals
162
$ 8,673,783
58.8%
$ 156,194
62.0%
Behavioral Health Facilities
68
2,407,964
16.3%
55,575
22.0%
Post Acute Care Facilities
128
1,668,629
11.3%
38,370
15.2%
Freestanding ER/Urgent Care Facilities
20
101,423
0.7%
1,926
0.8%
Other
-
1,910,878
12.9%
-
-
Total
378
$ 14,762,677
100.0%
$ 252,065
100.0%
TOTAL ASSETS BY ASSET TYPE TOTAL REVENUES BY ASSET TYPE
1%
11%
59%
16%
15%
22%
62%
13% 1%
General Acute Care Hospitals Behavioral Health Facilities Post Acute Care Facilities
Freestanding ER/Urgent Care Facilities Other
1%
13%
60%
12%
DOMESTIC ASSETS BY ASSET TYPE 14%
General Acute Care Hospitals Behavioral Health Facilities Post Acute Care Facilities
Freestanding ER/Urgent Care Facilities
DOMESTIC REVENUES BY ASSET TYPE 1%
Other
22%
17%
60%
Note: Investments in operating entities are allocated pro rata based on the gross book value of the real estate. Such pro rata allocations are subject to change from period to period.
(A) Reflects total assets on our consolidated balance sheets.
Largest Individual
Operators Facility as a Percentage of Total Assets(A)
Circle Health
1.3%
Priory Group
0.9%
Healthcare Systems of America
1.8%
Swiss Medical Network
1.8%
Lifepoint Behavioral Health
0.5%
46 operators
1.6%
Largest Individual Facility Investment is Less Than 2% of MPT Investment Portfolio
(March 31, 2026)
COMPREHENSIVE PROPERTY-LEVEL UNDERWRITING FRAMEWORK
MPT invests in real estate, not the consolidated financial performance of its tenants. Each facility is underwritten for characteristics that make the infrastructure attractive to any experienced, competent operator - not just the current tenant. If we have underwritten these correctly, then coupled with our absolute net master lease structure, our real estate will be attractive to a replacement operator, should we find it necesssary to transition. Such underwriting characteristics include:
(March 31, 2026)
Operators
Properties
Total Assets(A)
Percentage of Total Assets
Q1 2026
Revenues
Circle Health
36
$ 2,069,009
14.0%
$ 54,961
Priory Group
37
1,273,725
8.6%
27,496
Healthcare Systems of America
8
1,209,459
8.2%
17,406
Swiss Medical Network
19
868,978
5.9%
991
Lifepoint Behavioral Health
19
806,344
5.5%
21,346
MEDIAN
82
687,771
4.6%
9,022
Ernest Health
28
615,836
4.2%
19,231
NOR Healthcare Systems
6
528,525
3.6%
-
Lifepoint Health
8
453,236
3.1%
15,434
Ramsay Health Care
8
395,899
2.7%
6,797
41 operators
127
3,943,017
26.7%
79,381
Other
-
1,910,878
12.9%
-
Total
378
$ 14,762,677
100.0%
$ 252,065
($ amounts in thousands)
Demographics and Market
Competition
Percentage of Q1 2026 Revenues
(A) Reflects total assets on our consolidated balance sheets.
21.8%
10.9%
6.9%
0.4%
8.5%
3.6%
7.6%
-6.1%
2.7%
31.5%
-
100.0%
(March 31, 2026)
($ amounts in thousands)
U.S. States and Other Countries
Properties
Total Assets(A)
Percentage of Total Assets
Q1 2026
Revenues
Percentage of Q1 2026 Revenues
Texas
43
$ 1,403,311
9.5%
$ 27,015
10.7%
California
17
1,024,998
7.0%
15,324
6.1%
Florida
6
832,712
5.6%
11,308
4.5%
Arizona
8
329,471
2.2%
9,496
3.8%
Ohio
9
317,842
2.2%
6,507
2.6%
25 Other States
71
2,422,158
16.4%
65,211
25.8%
Other
-
1,046,367
7.1%
-
-
United States
154
$ 7,376,859
50.0%
$ 134,861
53.5%
United Kingdom
92
$ 4,084,982
27.7%
$ 96,396
38.2%
Switzerland
19
868,978
5.9%
991
0.4%
Germany
86
761,421
5.1%
11,265
4.5%
Spain
9
306,718
2.1%
3,291
1.3%
Other Countries
18
499,208
3.4%
5,261
2.1%
Other
-
864,511
5.8%
-
-
International
224
$ 7,385,818
50.0%
$ 117,204
46.5%
Total
378
$ 14,762,677
100.0%
$ 252,065
100.0%
Note: Investments in operating entities are allocated pro rata based on the gross book value of the real estate. Such pro rata allocations are subject to change from period to period.
(A) Reflects total assets on our consolidated balance sheets.
TOTAL ASSETS BY COUNTRY TOTAL REVENUES BY COUNTRY
1%
4%
38%
54%
3%
6%
2%
5%
6%
50%
28%
1% 2%
ASSETS BY U.S. STATE REVENUES BY U.S. STATE
7%
10%
Texas
California
11%
16%
7%
Florida Arizona
Ohio
26%
6%
25 Other States
4%
2% 2%
6%
Other
3%
4%
PORTFOLIO INFORMATION
YoY and SEQUENTIAL QUARTER COMPARISONS BY PROPERTY TYPE
3.50x
EBITDARM Rent Coverage
3.0x
3.0x
2.9x
2.5x
2.6x
2.5x
2.4x
2.2x
2.0x
1.9x
1.7x
1.5x
3.00x
2.50x
2.00x
1.50x
1.00x
0.50x
0.00x
General Acute Care Hospitals Post Acute Care Facilities (C)
Behavioral Health Facilities (D)
Total Portfolio
58.8%
11.3%
% of Total Assets(E)
16.3%
86.4%
Notes: All data presented is on a trailing twelve month ("TTM") basis. For properties acquired in the preceding twelve months, data is for the period between MPT acquisition and December 31, 2025.
EBITDARM is facility-level earnings before interest, taxes, depreciation, amortization, rent and management fees. EBITDARM includes normal GAAP expensed maintenance and repair costs. EBITDARM does not give effect for capitalized expenditures that extend the life or improve the facility and equipment to increase revenues at the facility. The majority of these types of capital expenditures are financed and do not have an immediate cash impact. MPT's rent has priority and is not subordinate to capitalized expenses. In addition, EBITDARM does not represent property net income or cash flows from operations and should not be considered an alternative to those indicators. EBITDARM figures utilized in calculating coverages presented are based on financial information provided by MPT's tenants. Where MPT owns assets through unconsolidated joint ventures, MPT's proportionate share of EBITDARM and Rent is included. MPT has not independently verified this information, but has no reason to believe this information is inaccurate in any material respect. TTM Coverages are calculated based on actual, unadjusted EBITDARM results as presented in tenant financial reporting and cash rent paid to MPT, except as noted below.
- EBITDARM figures for California hospitals include amounts expected to be received under the Hospital Quality Assurance Fee ("HQAF") Program 8. The HQAF amounts are based on the current payment model from the California Hospital Association which was approved by CMS on December 19, 2023.
General Acute Care coverages, Behavioral Health coverages and Total Portfolio coverages do not include operators whose data is not required, available, or re-tenanted during 2024-2025.
Pos-t Acute Care Facilities property type includes both Inpatient Rehabilitation Hospitals and Long Term Acute Care Hospitals.
We have revised our allocated central costs for Priory Group to better reflect retrospective, recent, and future facility-level actual performance. On a retrospective basis, these changes reduce trailing
twelve month coverage by 40 bps for Priory Group and 20 bps for the Behavioral Health property type, with no impact on the consolidated portfolio.
Reflects percentage of total assets on March 31, 2026 balance sheet.
TOTAL PORTFOLIO TTM EBITDARM RENT COVERAGE
EBITDARM RENT COVERAGE: OPERATORS WITH PROPERTY-LEVEL REPORTING
Tenant Net Investment Primary Property Type TTM EBITDARM Rent Coverage(B)
(in thousands)(A)
Priory Group
$
1,227,881
Behavioral
1.6x
MEDIAN
659,360
Post Acute
2.3x
Ernest Health
615,836
Post Acute
2.5x
Swiss Medical Network
595,630
General Acute
1.9x
Aspris Children's Services
242,414
Behavioral
2.1x
Surgery Partners
223,470
General Acute
5.8x
Pipeline Health System
194,900
General Acute
2.8x
Vibra Healthcare
152,198
Post Acute
3.0x
Prime Healthcare
155,807
General Acute
2.4x
IMED Hospitales
131,279
General Acute
1.9x
Other Reporting Tenants
573,928
Various
2.9x
Total
$
4,772,703
2.5x
Tenant Net Investment Primary Property Type TTM EBITDARM Rent Coverage (in thousands)(A)
International Operator 1
$
2,023,378
General Acute
2.6x
Domestic Operator 1
453,236
General Acute
2.0x
Domestic Operator 2
259,010
General Acute
2.6x
Domestic Operator 3
806,344
Behavioral
1.2x
Domestic Operator 4
78,944
General Acute
9.4x
Total
$
3,620,912
2.5x
PROPERTY-LEVEL REPORTING NOT REQUIRED AND/OR NOT AVAILABLE
Tenant
Net Investment
(in thousands)(A)
Primary Property Type
Comments
Healthcare Systems of America $ 1,115,328 General Acute
Ramsay Health Care 395,899 General Acute
U.S. hospital operator with eight community hospitals across
NOR Healthcare Systems
505,181
General Acute
U.S. hospital operator with six general acute hospitals in California
three states
One of the largest healthcare operators in the world; Parent guaranty; Investment grade-rated
Pihlajalinna 215,630 General Acute One of Finland's leading providers of social and health services
CommonSpirit Health 169,269 General Acute
One of the largest nonprofit healthcare operators in the U.S.; Investment grade-rated
Quorum Health
117,660
General Acute
U.S. hospital operator with eleven community hospitals across nine states
HonorHealth 131,129 General Acute
One of Arizona's largest nonprofit healthcare systems;
Investment grade-rated
Saint Luke's - Kansas City
117,973
General Acute
U.S. hospital operator with investment grade-rating and largest nonprofit healthcare organization in Missouri
NHS 85,482 General Acute Single-payor government entity in UK
Select Medical
52,664
Post Acute
Publicly-traded and one of the largest post acute operators in the U.S.
Insight Health 48,925 General Acute
U.S. hospital operator with eight medical centers across four
states
NeuroPsychiatric Hospitals
25,563
Behavioral
U.S. hospital operator with nine behavioral health hospitals; Parent guaranty
Community Health Systems 23,987 General Acute Publicly-traded U.S. hospital operator
Tenor Health 19,215 General Acute U.S. hospital operator focused on turnaround opportunities
AHRK Holdings 7,537 General Acute U.S. hospital operator with two community hospitals in Texas
Total $ 3,031,442
Above data represents approximately 91% of MPT Total Real Estate Investment
Notes: All data presented is on a trailing twelve month ("TTM") basis. For properties acquired in the preceding twelve months, data is for the period between MPT acquisition and December 31, 2025.
Investment figures exclude equity investments, non-real estate loans, freestanding ER/urgent care facilities, and facilities under development.
General Acute Care coverages, Behavioral Health coverages and Total Portfolio coverages do not include operators whose data is not required, available, or re-tenanted during 2024-2025.
SUMMARY OF ACTIVE DEVELOPMENTS AND CAPITAL ADDITION PROJECTS AS OF March 31, 2026(A)
(Amounts in thousands)
Operator
Location
Commitment
Costs Incurred as of March 31, 2026
Cost Remaining
Estimated Construction Completion Date
IMED
Spain
$ 42,780
$ 42,594
$ 186
2Q26
IMED
Spain
65,952
49,820
16,132
4Q26
Healthcare Systems of America
Florida
43,500
4,421
39,079
2Q27
NOR Healthcare Systems
California
24,333
289
24,044
3Q27
Other Various
554
210
344
2Q26
$ 177,119
$ 97,334
$ 79,785
(A) In addition to the above projects, the costs of which will be included in lease bases upon which the lessees will pay rent, we are constructing two hospitals for which there is no presently-identified lessee; these projects were both originally planned to be operated by a former tenant. We have completed construction to the stage where the building is "weathered in" and environmentally secure so as to physically protect our investment while we actively market the hospitals for sale or lease. As of March 31, 2026, we estimate that the cost of additional construction that we believe will be more efficient if completed in the near term (such as electing to accelerate completion of a parking structure at one hospital), approximates between $5 million and $10 million. If we agree to lease terms for any prospective tenant, we expect such terms will include construction specifications of such prospective lessee, and we may elect to fund such completion for addition to the final lease base upon which we would be paid rent. Alternatively, we may elect to sell one or both of the facilities, in which case we would not expect to incur material additional costs.
(Unaudited)
(Amounts in thousands, except per share data)
March 31, 2026
March 31, 2025
For the Three Months Ended
REVENUES
Rent billed
$
197,520
$
165,190
Straight-line rent
34,196
40,127
Income from financing leases
10,064
9,905
Interest and other income
10,285
8,577
Total revenues
252,065
223,799
EXPENSES
Interest
133,330
115,801
Real estate depreciation and amortization
69,717
64,572
Property-related(A)
9,940
7,035
General and administrative
32,205
41,911
Total expenses
245,192
229,319
OTHER (EXPENSE) INCOME
(Loss) gain on sale of real estate
(790)
8,059
Real estate and other impairment charges, net
(19,032)
(76,102)
Earnings from equity interests
15,739
13,986
Debt refinancing and unutilized financing costs
-
(3,796)
Other (including fair value adjustments on securities)
(2,505)
(45,206)
Total other expense
(6,588)
(103,059)
Income (loss) before income tax
(108,579)
Income tax benefit (expense)
(9,437)
Net income (loss)
(118,016)
Net income attributable to non-controlling interests
(259)
Net income (loss) attributable to MPT common stockholders
$ (118,275)
EARNINGS PER COMMON SHARE - BASIC AND DILUTED
Net income (loss) attributable to MPT common stockholders
$
0.05
$
(0.20)
WEIGHTED AVERAGE SHARES OUTSTANDING - BASIC
597,715
600,594
WEIGHTED AVERAGE SHARES OUTSTANDING - DILUTED
597,715
600,594
DIVIDENDS DECLARED PER COMMON SHARE
$
0.09
$
0.08
285
32,822
33,107
(280)
$ 32,827
(A) Includes $1.9 million and $1.9 million of ground lease and other expenses (such as property taxes and insurance) paid directly by us and reimbursed by our tenants for the three months ended March 31, 2026 and 2025, respectively.
March 31, 2026
December 31, 2025
(Unaudited)
(A)
$ 12,109,743
$ 12,205,687
381,589
421,684
124,479
123,651
12,615,811
12,751,022
(1,713,282)
(1,663,056)
10,902,529
11,087,966
425,001
540,859
17,981
19,210
904,075
881,452
1,390,385
1,399,777
320,928
322,179
237,957
186,292
563,821
564,040
$ 14,762,677
$ 15,001,775
$ 9,662,659
$ 9,697,835
433,165
549,105
18,580
19,289
102,514
128,297
10,216,918
10,394,526
-
-
598
597
8,577,846
8,573,396
(4,157,439)
(4,136,011)
123,700
168,213
4,544,705
4,606,195
1,054
1,054
4,545,759
4,607,249
$ 14,762,677
$ 15,001,775
(Amounts in thousands, except per share data)
ASSETS
Real estate assets
Land, buildings and improvements, intangible lease assets, and other Investment in financing leases
Mortgage loans
Gross investment in real estate assets Accumulated depreciation and amortization Net investment in real estate assets
Cash and cash equivalents Interest and rent receivables Straight-line rent receivables
Investments in unconsolidated real estate joint ventures Investments in unconsolidated operating entities
Other loans Other assets
Total Assets
LIABILITIES AND EQUITY
Liabilities
Debt, net
Accounts payable and accrued expenses Deferred revenue
Obligations to tenants and other lease liabilities
Total Liabilities
Equity
Preferred stock, $0.001 par value. Authorized 10,000 shares; no shares outstanding
Common stock, $0.001 par value. Authorized 750,000 shares; issued and outstanding - 597,715 shares at March 31, 2026 and 597,008 shares at December 31, 2025
Additional paid-in capital Retained deficit
Accumulated other comprehensive income
Total Medical Properties Trust, Inc. stockholders' equity Non-controlling interests
Total Equity
Total Liabilities and Equity
(A) Financials have been derived from the prior year audited financial statements.
INVESTMENTS IN UNCONSOLIDATED REAL ESTATE JOINT VENTURES
(As of and for the three months ended March 31, 2026) (Unaudited)
($ amounts in thousands)
Gross real estate Cash
Accumulated depreciation and amortization
Other assets
MEDIAN(B)
2,060,746 $
25,792
(363,739)
123,213
Swiss Medical Network(C)
1,874,016
1,170
(248,067)
93,000
CommonSpirit(D)
$
1,479,521
3,667
-8,567
$
Policlinico di Monza(E)
193,649
17,733
(44,851)
4,268
$
HM
Hospitales(F)
391,148
1,664
(53,331)
11,284
Total
$
$
5,999,080 $
50,026
(709,988)
240,332
MPT Pro Rata Share
2,988,643
24,251
(402,337)
136,213
Total Assets
$ 1,846,012 $ 1,720,119 $ 1,491,755 $
170,799 $
350,765 $ 5,579,450 $ 2,746,770
$ 778,705 $
119,067
948,240 (A)
706,175 $
144,795
869,149
770,000 $
46,029
675,726
- $
(207)
171,006
150,066 $ 2,404,946 $ 1,145,220
85,815 395,499 211,165
114,884 2,779,005 1,390,385
$ 1,846,012 $ 1,720,119 $ 1,491,755 $
170,799 $
350,765 $ 5,579,450 $ 2,746,770
Debt (third party) Other liabilities
Equity and shareholder loans
Total Liabilities and Equity
MPT share of real estate joint venture
50% 70%
25%
50%
45%
Total
$
474,120 $
609,795 $
169,269 $
85,503 $
51,698
MEDIAN(B)
36,697
Swiss Medical
Network(C)
CommonSpirit(D)
Policlinico di Monza(E)
3,904
HM
Hospitales(F)
4,912
Total
Total revenues
Other expenses (income): Property-related
Interest
Real estate depreciation and amortization General and administrative
Fair value adjustments Loss on sale of real estate Income and other taxes
Non-controlling interest expense
$
$
24,341
$
24,865
$
$
$
94,719
MPT Pro Rata Share
$ 45,818
$
Total other expenses (income)
$
947
20,988
12,304
722
-
-1,668
-
36,629
$
$
1,570
3,623
10,616
508
-1,747
126
-
18,190
$
$
5
13,056
-
-(28,587)
-
-69
(15,457)
$
$
1,117
-1,138
(23)
-
-
-
-
2,232
$
$
649
583
2,243
20
-
-361
-
3,856
$
$
4,288
38,250
26,301
1,227
(28,587)
1,747
2,155
69
45,450
$
$
2,427
16,569
15,178
715
(7,161)
1,226
1,085
17
30,056
Net income
$
68 $
6,151 $
40,322 $
1,672 $
1,056 $
49,269 $
15,762
MPT share of real estate joint venture
50%
70%
25%
50%
45%
Earnings from equity interests
$
34 $
4,316 $
10,101 $
836 $
475
$ 15,762
$ 1,390,385
(G)
Includes a €309 million loan from both shareholders.
MPT managed joint venture of 71-owned German facilities that are fully leased.
Represents ownership in Infracore, which owns and leases 18 Switzerland facilities. We also have one Infracore facility currently under development.
Represents ownership in five Utah facilities that are fully leased. The joint venture elected to apply specialized accounting and reporting for investment companies under Topic 946, which measures the underlying investments at fair value. For this quarter, our share of the joint venture's favorable fair value adjustment was $7.2 million, primarily related to real estate.
Represents ownership in eight Italian facilities that are fully leased.
Represents ownership in two Spanish facilities that are fully leased.
Excludes $23,000 of amortization of equity investment costs.
INVESTMENTS IN UNCONSOLIDATED OPERATING ENTITIES
(Amounts in thousands)
OPERATING ENTITY INVESTMENT FRAMEWORK
MPT's hospital expertise and comprehensive underwriting process allows for opportunistic investments in hospital operations.
Passive investments typically needed in order to acquire the larger real estate transactions.
Cash payments go to previous owner and not to the tenant, with limited exceptions.
Operators are vetted as part of our overall underwriting process.
Potential for outsized returns and organic growth.
Certain of these investments entitle us to customary minority rights and protections.
Typically, no additional operating loss exposure beyond our investment.
Proven track record of successful investments, including Ernest Health, Capella Healthcare and Springstone.
Investment as of
March 31, 2026
Operator
Ownership Interest
Structure
Swiss Medical Network
$ 195,838
8.9% Includes our passive equity ownership interest, along with a CHF 37 million loan as part of a syndicated loan facility.
Aevis
63,346
4.6% Includes our passive equity ownership interest in Aevis, a public healthcare investment company. Our original investment of CHF 47 million is marked-to-market quarterly.
Priory Group
45,844
9.2% In order to close the 2021 acquisition of 35 facilities, we made an investment in Priory, proceeds of which
were paid to the former owner.
Aspris
15,900
9.2%
Includes our passive equity ownership interest in Aspris, a spin-off of Priory's education and children's services line of business.
Total
$ 320,928
INVESTMENTS IN UNCONSOLIDATED OPERATING ENTITIES AS A PERCENTAGE OF TOTAL ASSETS
98%
2%
APPENDIX - NON-GAAP RECONCILIATIONS
(Unaudited)
(Amounts in thousands)
For the Three Months Ended
March 31, 2026
ADJUSTED EBITDAre RECONCILIATION
Net income
$ 33,107
Interest
133,330
Income tax
(32,822)
Depreciation and amortization
73,348
Loss on sale of real estate
790
Real estate impairment charges
9,037
from unconsolidated real estate joint ventures(A)
9,776
1Q 2026 EBITDAre
$ 226,566
Share-based compensation
573
Other impairment charges, net
10,469
Litigation, bankruptcy and other costs
1,632
Non-cash fair value adjustments
(5,568)
Annualized
1Q 2026 Adjusted EBITDAre
$ 233,672 $ 934,688
Adjustments for mid-quarter investment activity(B)
(507)
1Q 2026 Transaction Adjusted EBITDAre
$ 233,165 $ 932,660
ADJUSTED NET DEBT RECONCILIATION
Total debt at March 31, 2026
$
9,662,659
Less: Cash at March 31, 2026
(425,001)
Less: Cash funded for development and capital
addition projects at March 31, 2026(C)
(544,025)
Adjusted Net Debt
$ 8,693,633
Add back:
Adjustment to reflect MPT's share of unlevered EBITDAre
Investors and analysts following the real estate industry utilize net debt (debt less cash) to EBITDAre as a measurement of leverage that shows how many years it would take for us to pay back our debt, assuming net debt and EBITDAre are held constant. In our calculation, we start with EBITDAre, as defined by Nareit, which is net income before interest expense, income tax expense, depreciation and amortization, losses/gains on disposition of depreciated property, impairment losses, and adjustments to reflect our share of EBITDAre from unconsolidated real estate joint ventures. We then adjust EBITDAre for non-cash share-based compensation, non-cash fair value adjustments and other items that would make comparison of our operating results with prior periods and other companies more meaningful, to derive Adjusted EBITDAre. We adjust net debt for cash funded for building improvements in progress and construction in progress for which we are not yet receiving rent (but will generate a return once completed) to derive Adjusted Net Debt. We adjust Adjusted EBITDAre for the effects from investments and capital transactions that were completed during the period, assuming such transactions were consummated/fully funded as of the beginning of the period to derive Transaction Adjusted EBITDAre. Although non-GAAP measures, we believe Adjusted Net Debt, Adjusted EBITDAre, and Transaction Adjusted EBITDAre are useful to investors and analysts as they allow for a more current view of our credit quality and allow for the comparison of our credit strength between periods and to other real estate companies without the effect of items that by their nature are not comparable from period to period.
Includes only the unlevered portion of our share of EBITDAre from unconsolidated real estate joint ventures, as we have excluded any net debt from our unconsolidated real estate joint ventures in the Adjusted Net Debt line. We believe this adjustment is needed to appropriately reflect the relationship between EBITDAre and net debt.
Reflects a full quarter impact from our mid-quarter investments, disposals, and loan payoffs.
Reflects development and capital improvement projects that are in process and not yet generating a cash return.
Disclaimer
Medical Properties Trust Inc. published this content on April 30, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 30, 2026 at 12:28 UTC.